4 results

  • bupropion hydrochloride

    (bupropion hydrochloride)
    Alvogen Inc.
    Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) in adults. Efficacy was established in controlled trials for both acute treatment and maintenance therapy. Regular reevaluation of the drug's long-term usefulness is recommended for ongoing patient care.

  • lisdexamfetamine dimesylate

    (lisdexamfetamine dimesylate)
    Alvogen Inc.
    Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss due to associated cardiovascular risks and lack of established safety.

  • naproxen sodium

    (Naproxen Sodium)
    Alvogen Inc.
    Naproxen Sodium Controlled-Release Tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and to relieve mild to moderate pain.

  • oseltamivir phosphate for oral suspension

    (Oseltamivir Phosphate)
    Alvogen Inc.
    Oseltamivir phosphate for oral suspension is indicated for the treatment of influenza in patients who have been symptomatic for no more than two days. It is not a substitute for annual influenza vaccination and is contraindicated in patients with end-stage renal disease not undergoing dialysis.